Cart
sales@molnova.com
DL -34-Dihydroxymandelic acid
CAS No. 14883-87-5
DL -34-Dihydroxymandelic acid ( —— )
Catalog No. M20114 CAS No. 14883-87-5
34-Dihydroxymandelic acid is a minor metabolite of norepinephrine in humans. Patients with neuroblastoma experience elevated levels of 34-Dihydroxymandelic acid.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 50MG | 92 | Get Quote |
|
| 100MG | 138 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDL -34-Dihydroxymandelic acid
-
NoteResearch use only not for human use.
-
Brief Description34-Dihydroxymandelic acid is a minor metabolite of norepinephrine in humans. Patients with neuroblastoma experience elevated levels of 34-Dihydroxymandelic acid.
-
Description34-Dihydroxymandelic acid is a minor metabolite of norepinephrine in humans. Patients with neuroblastoma experience elevated levels of 34-Dihydroxymandelic acid.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number14883-87-5
-
Formula Weight184.15
-
Molecular FormulaC8H8O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESOC(C(O)=O)c1ccc(O)c(O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Goldstein DS et al. Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther. 2003 Jun;305(3):800-11.
molnova catalog
related products
-
PKG Substrate
PKG Substrate is a selective substrate for cGMP-dependent protein kinase (PKG).PKG Substrate is a selective substrate for protein kinase G (PKG) with a strong preference for PKG Iα (Km = 59 μM) over PKG II (Km = 305 μM).
-
Danshenxinkun A
Danshenxinkun A, Danshenxinkun B and Neocryptotanshinone may intervene thrombotic diseases by adjusting the targets mainly involved in pathways of endocrine system, signal transduction, signaling molecules and interaction, cell motility, environmental adaptation and nervous system.
-
SJ572403
SJ572403 is an inhibitor of disordered protein p27.
